AtaiBeckley Inc.
EMP-01
Social Anxiety Disorder
Resolved
131days ago
Phase 2 readout · Feb 26, 2026
What's at stake
Phase 2 trial results for EMP-01 in Social Anxiety Disorder are due Feb 26, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 16h ago
“Conference call scheduled for 8:00 a.m. ET today, February 26, 2026, at which AtaiBeckley announced topline results from its exploratory Phase 2a study of EMP-01 in Social Anxiety Disorder.”